Skip to main content
Equibles

STATE STREET CORP

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 93751 BOSTON, MA
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$67,531,535
-$1,090,036 QoQ
Shares Held
1,072,951
+9.7% QoQ
Ownership
2.45%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 256 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 21% Shared 0% None 79%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. TARS ranks #98 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in TARS

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $67,531,535 1,072,951
2026-03-31 $68,621,571 978,212
2025-12-31 $76,071,350 929,059
2025-09-30 $55,636,107 936,162
2025-06-30 $39,734,962 980,868
2025-03-31 $46,783,480 910,716
2024-12-31 $50,766,316 916,856
2024-09-30 $29,580,575 899,379
2024-06-30 $25,158,868 925,639
2024-03-31 $26,066,221 717,090
2023-12-31 $13,665,327 674,831
2023-09-30 $9,683,441 544,932
2023-06-30 $7,602,338 420,716
2023-03-31 $4,579,188 364,295
2022-12-31 $5,082,035 346,660
2022-09-30 $5,018,060 293,111
2022-06-30 $3,453,133 236,516
2022-03-31 $2,235,092 132,883
2021-12-31 $2,919,195 129,742
2021-09-30 $2,732,583 126,802
2021-06-30 $3,452,706 119,141
2021-03-31 $3,235,376 100,384
2020-12-31 $4,004,215 96,884